Alnylam Pharmaceuticals
ALNY
$146.07
Share price
0.19%
Change (1 day)
-28.67%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Stock price history for Alnylam Pharmaceuticals (ALNY)
Highest end of day price: $241.31 USD on 2022-12-21
Lowest end of day price: $3.95 USD on 2004-08-16
Stock price history of Alnylam Pharmaceuticals from 2004 to 2024
Stock price for similar companies or competitors
| Company | Stock price | Change 1d% | Country |
|---|---|---|---|
 Novartis NVS | $97.28 | 2.27% | 🇨🇭 Switzerland |
 Sanofi SNY | $47.69 | 1.15% | 🇫🇷 France |
 Regeneron Pharmaceuticals REGN | $907.32 | 0.80% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $117.12 | 0.14% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $2.26 | 2.73% | 🇺🇸 USA |
 OPKO Health
OPK | $1.25 | 1.63% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $13.01 | 1.01% | 🇮🇱 Israel |
 Arrowhead Pharmaceuticals
ARWR | $23.78 | -0.59% | 🇺🇸 USA |